emids Acquires Quovantis Technologies in Latest Expansion of Human-centered, Design-led Product Development and Software Engineering Capabilities

Bengaluru | Thursday | 8th April, 2021

Summary:

emids, which has built its reputation as one of healthcare's most trusted partners for health information technology (HIT) engineering and development, is going strategically upstream with this latest deal on the heels of its acquisition earlier this year of design-led engineering firm Macadamian. “We take a human-centered and iterative approach to innovation,” said Quovantis Founder and CEO Tarun Kohli. Kohli describes Quovantis as, “The company that gets married to the users’ problems and creates delightful solutions using the combination of design, strong engineering culture, and iterative development approach. About emidsemids is a leading provider of digital transformation solutions to the healthcare industry, serving payers, providers, life sciences, and technology firms. With over 2,300 professionals globally, emids leverages strong domain expertise in healthcare-specific platforms, regulations, and standards to provide tailored, cutting-edge solutions and services to its clients..